- Home
- BCAB vs DLHC Comparison
BCAB vs DLHC Comparison
Compare BCAB & DLHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAB
- DLHC
- Stock Information
- Founded
- BCAB 2007
- DLHC 1969
- Country
- BCAB United States
- DLHC United States
- Employees
- BCAB N/A
- DLHC N/A
- Industry
- BCAB Medicinal Chemicals and Botanical Products
- DLHC Business Services
- Sector
- BCAB Health Care
- DLHC Consumer Discretionary
- Exchange
- BCAB Nasdaq
- DLHC Nasdaq
- Market Cap
- BCAB 101.0M
- DLHC 117.4M
- IPO Year
- BCAB 2020
- DLHC N/A
- Fundamental
- Price
- BCAB $1.57
- DLHC $8.53
- Analyst Decision
- BCAB Buy
- DLHC
- Analyst Count
- BCAB 2
- DLHC 0
- Target Price
- BCAB $5.00
- DLHC N/A
- AVG Volume (30 Days)
- BCAB 1.2M
- DLHC 55.7K
- Earning Date
- BCAB 11-07-2024
- DLHC 12-04-2024
- Dividend Yield
- BCAB N/A
- DLHC N/A
- EPS Growth
- BCAB N/A
- DLHC N/A
- EPS
- BCAB N/A
- DLHC 0.17
- Revenue
- BCAB $11,000,000.00
- DLHC $401,038,000.00
- Revenue This Year
- BCAB N/A
- DLHC $8.70
- Revenue Next Year
- BCAB N/A
- DLHC $6.10
- P/E Ratio
- BCAB N/A
- DLHC $48.90
- Revenue Growth
- BCAB N/A
- DLHC 17.39
- 52 Week Low
- BCAB $1.14
- DLHC $7.94
- 52 Week High
- BCAB $4.02
- DLHC $17.58
- Technical
- Relative Strength Index (RSI)
- BCAB 40.91
- DLHC 47.54
- Support Level
- BCAB $1.33
- DLHC $8.18
- Resistance Level
- BCAB $2.53
- DLHC $8.62
- Average True Range (ATR)
- BCAB 0.26
- DLHC 0.36
- MACD
- BCAB -0.07
- DLHC 0.01
- Stochastic Oscillator
- BCAB 20.08
- DLHC 35.98
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
About DLHC DLH Holdings Corp.
DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of Veteran Affairs. It is engaged in public health, performance evaluation, and health operations to solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, analytics, cloud-based applications, and telehealth systems.